A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
Clinical trial NCT03980054 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03980054
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-12
- Primary completion
- 2027-06-01
- Enrollment
- 2135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.